All insights
DHF checklistMarket-entry evidence readinessSource review as of 2026-06-08

FDA Design Controls and DHF Checklist for Medical Device Founders

When a design owner is preparing a design-file discussion before inspection, the problem is that inputs, risks, verification, validation, and changes may not be linked to the same product question. The useful output is a design-history review map that keeps source facts, owner questions, and qualified-review boundaries visible.

The useful output is a DHF evidence checklist: trigger, source links, product-similarity notes, internal evidence asks, owner, due date, and next qualified-review step.

For one design owner preparing a design-file discussion before inspection.

The founder design-review moment

Picture the medical-device founder in a design-review meeting before the DHF is inspected or diligenced. Engineering tickets look active, but activity does not prove design-control decisions.

The first move is not to declare whether the signal raises safety, compliance, reportability, equivalence, or exposure questions. The useful move is to map the signal to the product family, name missing evidence, and prepare questions for qualified RA/QA, clinical, quality, or leadership review.

DHF evidence checklist

Checklist rowWhat to capture
TriggerThe exact public record, customer event, executive question, or audit question that started the review.
Design evidenceDesign input, risk-control link, verification, validation, change history, supplier evidence, and labeling history.
ComparisonProduct code, intended use, technology, component, supplier, user setting, geography, and failure mode.
OwnerRA/QA, design engineering, supplier quality, clinical, operations, leadership, or legal owner for the next action.
BoundaryWhat was checked, what remains missing, and which decisions remain outside the checklist.

What good looks like

A useful DHF evidence checklist does not say the file is fine. It says which evidence was reviewed, which comparison was made, which uncertainty remains, which request is needed, and who owns the next step.

If the first pass finds a gap, that is useful. It means the workflow found the exact record, owner, or source question that should be handled before the next meeting.

Source ledger

FDA 510(k) Premarket Notification Database

What it can tell you

Public 510(k) records, device names, applicant names, decision dates, and product-code context that can frame comparator questions.

What it cannot decide

Whether a specific device is substantially equivalent, whether a DHF is sufficient, or whether one design-control record is acceptable.

FDA Medical Device Recalls and Early Alerts

What it can tell you

Public recall and early-alert signals that may raise design, supplier, labeling, software, or risk-file review questions.

What it cannot decide

Whether one team has a reportable event, a design-control failure, a CAPA requirement, or a recall obligation.

FDA Electronic Submission Template And Resource (eSTAR) Program

What it can tell you

FDA's electronic submission structure and preparation context for medical-device submissions that may involve design-control evidence.

What it cannot decide

Whether a specific design-control package, verification plan, validation plan, or submission strategy is acceptable.

Frequently asked questions

Does this checklist prove that a DHF is compliant?

No. It organizes design-control evidence and review questions. DHF sufficiency, compliance status, submission strategy, safety, and effectiveness decisions remain with qualified reviewers.

What should a founder prepare first?

Prepare the trigger, design evidence map, missing records, owner list, and next review question before trying to summarize the DHF in one slide.

Need a DHF evidence checklist before the next review call?

Send the product family, review trigger, and current evidence list. We can scope a source-backed DHF checklist for qualified review.

Reader feedback

Useful pages should feed the next topic choices. Leave a signal or a short comment.

0 approved comments0 awaiting review
Comments are reviewed before they appear publicly. Keep it non-confidential and focused on what helped or what was still unclear.